Publication Date
12-1-2023
Journal
Cardiol Therapeutics
DOI
10.1007/s40119-023-00329-2
PMID
37668939
PMCID
PMC10703757
PubMedCentral® Posted Date
9-5-2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Acute coronary syndrome, Aortic stenosis, Coronary physiology, FFR, Heart failure, iFR, Post-PCI, Serial stenosis
Abstract
Coronary angiography has a limited ability to predict the functional significance of intermediate coronary lesions. Hence, physiological assessment of coronary lesions, via fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR), has been introduced to determine their functional significance. An accumulating body of evidence has consolidated the role of physiology-guided revascularization, particularly among patients with stable ischemic heart disease. The use of FFR or iFR to guide decision-making in patients with stable ischemic heart disease and intermediate coronary lesions received a class I recommendation from major societal guidelines. Nevertheless, the role of coronary physiology testing is less clear among certain patients' groups, including patients with serial coronary lesions, acute coronary syndromes, aortic stenosis, heart failure, as well as post-percutaneous coronary interventions. In this review, we aimed to discuss the utility and clinical evidence of coronary physiology (mainly FFR and iFR), with emphasis on those specific patient groups.
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Cardiology Commons, Cardiovascular Diseases Commons, Critical Care Commons, Medical Sciences Commons